Advertisement

Wiener klinische Wochenschrift

, Volume 119, Supplement 3, pp 8–12 | Cite as

History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon

  • Michael Ramharter
  • Ayola A. Adegnika
  • Selidji T. Agnandji
  • Pierre Blaise Matsiegui
  • Martin P. Grobusch
  • Stefan Winkler
  • Wolfgang Graninger
  • Sanjeev Krishna
  • Maria Yazdanbakhsh
  • Benjamin Mordmüller
  • Bertrand Lell
  • Michel A. Missinou
  • Elie Mavoungou
  • Saadou Issifou
  • Peter G. KremsnerEmail author
Review Article

Summary

In 1913 Albert Schweitzer founded one of the first modern hospitals in Africa dedicated to the health of the local population. The Albert Schweitzer Hospital is located in Lambaréné, a small town in Gabon. In 1981 a research department – the Medical Research Unit – was established with the aim to perform research in the field of infectious diseases (www.lambarene.org). The main focus lies on clinical research on malaria and other parasitic diseases. Studies on the molecular biology and immunology of parasitic diseases are fostered since the inauguration of a novel building dedicated for basic science. A training program in clinical research in tropical diseases for African scientists has been set up recently.

Key words

Albert Schweitzer Hospital Gabon Malaria Clinical research Tropical medicine 

Geschichte und Zukunft der Medizinischen Forschung am Albert Schweitzer Spital in Lambaréné, Gabun

Zusammenfassung

Albert Schweitzer gründete 1913 in Lambaréné, Gabun, eines der ersten tropischen Spitäler, das vorrangig der Gesundheitsversorgung der einheimischen Bevölkerung gewidmet war. 1981 wurde am Albert Schweitzer Spital eine medizinische Forschungseinrichtung gegründet (www.lambarene.org). Diese Einrichtung entwickelte sich in den letzten 15 Jahren zu einer der weltweit führenden Forschungsstätten im Bereich der klinischen tropenmedizinischen Forschung, besonders im Bereich der Malaria. Durch den Bau eines eigens für molekularbiologische und immunologische Forschung bestimmten Gebäudes wird nun auch die Grundlagenforschung am Albert Schweitzer Spital möglich. Kürzlich wurde auch ein in Afrika einzigartiger postgradueller Lehrgang in Klinischer Forschung etabliert.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kremsner PG, Krishna S (2004) Antimalarial combinations. Lancet 364 (9430): 285–294PubMedCrossRefGoogle Scholar
  2. Lell B, Kremsner PG (2002) Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob Agents Chemother 46 (8): 2315–2320PubMedCrossRefGoogle Scholar
  3. Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzle U, Graninger W (1994) Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis 69 (2): 467–470Google Scholar
  4. Kremsner PG, Winkler S, Brandts C, Graninger W, Bienzle U (1993) Curing of chloroquine-resistant malaria with clindamycin. Am J Trop Med Hyg 49 (5): 650–654PubMedGoogle Scholar
  5. Lell B, Luckner D, Ndjave M, Scott T, Kremsner PG (1998) Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children. Lancet 351 (9104): 709–713PubMedCrossRefGoogle Scholar
  6. Radloff PD, Philipps J, Nkeyi M, Hutchinson D, Kremsner PG (1996) Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 347 (9014): 1511–1514PubMedCrossRefGoogle Scholar
  7. Faucher JF, Binder R, Missinou MA, Matsiegui PB, Gruss H, Neubauer R, et al (2002) Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines. Clin Infect Dis 35 (10): 1147–1154PubMedCrossRefGoogle Scholar
  8. Lell B, Faucher JF, Missinou MA, Borrmann S, Dangelmaier O, Horton J, et al (2000) Malaria chemoprophylaxis with tafenoquine: a randomised study. Lancet 355 (9220): 2041–2045PubMedCrossRefGoogle Scholar
  9. Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, et al (2002) Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359 (9315): 1365–1372PubMedCrossRefGoogle Scholar
  10. Alloueche A, Bailey W, Barton S, Bwika J, Chimpeni P, Falade CO, et al (2004) Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial. Lancet 363 (9424): 1843–1848PubMedCrossRefGoogle Scholar
  11. Borrmann S, Lundgren I, Oyakhirome S, Impouma B, Matsiegui PB, Adegnika AA, et al (2006) Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria. Antimicrob Agents Chemother 50 (8): 2713–2718PubMedCrossRefGoogle Scholar
  12. Borrmann S, Adegnika AA, Moussavou F, Oyakhirome S, Esser G, Matsiegui PB, et al (2005) Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother 49 (9): 3749–3754PubMedCrossRefGoogle Scholar
  13. Missinou MA, Borrmann S, Schindler A, Issifou S, Adegnika AA, Matsiegui PB, et al (2002) Fosmidomycin for malaria. Lancet 360 (9349): 1941–1942PubMedCrossRefGoogle Scholar
  14. Oyakhirome S, Issifou S, Pongratz P, Barondi F, Ramharter M, Kun JF, et al (2007) Fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria: a randomised controlled trial. Antimicrob Agents Chemother 51 (5): 1869–1871PubMedCrossRefGoogle Scholar
  15. Ramharter M, Oyakhirome S, Klouwenberg PK, Adegnika AA, Agnandji ST, Missinou MA, et al (2005) Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. Clin Infect Dis 40 (12): 1777–1784PubMedCrossRefGoogle Scholar
  16. Adegnika AA, Breitling LP, Agnandji ST, Chai SK, Schutte D, Oyakhirome S, et al (2005) Effectiveness of quinine monotherapy for the treatment of Plasmodium falciparum infection in pregnant women in Lambarene, Gabon. Am J Trop Med Hyg 73 (2): 263–266PubMedGoogle Scholar
  17. Ramharter M, Grobusch MP, Kiessling G, Adegnika AA, Moller U, Agnandji ST, et al (2005) Clinical and parasitological characteristics of puerperal malaria. J Infect Dis 191 (6): 1005–1009PubMedCrossRefGoogle Scholar
  18. Ramharter M, Chai SK, Adegnika AA, Klopfer A, Langin M, Agnandji ST, et al (2004) Shared breastfeeding in central Africa. AIDS 18 (13): 1847–1849PubMedCrossRefGoogle Scholar
  19. Kun JF, Mordmuller B, Lell B, Lehman LG, Luckner D, Kremsner PG (1998) Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351 (9098): 265–266PubMedCrossRefGoogle Scholar
  20. Kun JF, Mordmuller B, Perkins DJ, May J, Mercereau-Puijalon O, Alpers M, et al (2001) Nitric oxide synthase 2 (Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis 184 (3): 330–336PubMedCrossRefGoogle Scholar
  21. Uhlemann AC, Szlezak NA, Vonthein R, Tomiuk J, Emmer SA, Lell B, et al (2004) DNA phasing by TA dinucleotide microsatellite length determines in vitro and in vivo expression of the gp91phox subunit of NADPH oxidase and mediates protection against severe malaria. J Infect Dis 189 (12): 2227–2234PubMedCrossRefGoogle Scholar
  22. Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, et al (1999) Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis 179 (4): 980–988PubMedCrossRefGoogle Scholar
  23. Greve B, Lehman LG, Lell B, Luckner D, Schmidt-Ott R, Kremsner PG (1999) High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria. J Infect Dis 179 (6): 1584–1586PubMedCrossRefGoogle Scholar
  24. Greve B, Kremsner PG, Lell B, Luckner D, Schmid D (2000) Malarial anaemia in African children associated with high oxygen-radical production. Lancet 355 (9197): 40–41PubMedCrossRefGoogle Scholar
  25. Bouyou-Akotet MK, Adegnika AA, Agnandji ST, Ngou-Milama E, Kombila M, Kremsner PG, et al (2005) Cortisol and susceptibility to malaria during pregnancy. Microbes Infect 7 (11–12): 1217–1223PubMedCrossRefGoogle Scholar
  26. Mavoungou E, Luty AJ, Kremsner PG (2003) Natural killer (NK) cell-mediated cytolysis of Plasmodium falciparum infected human red blood cells in vitro. Eur Cytokine Netw 14 (3): 134–142PubMedGoogle Scholar
  27. Mavoungou E, Held J, Mewono L, Kremsner PG (2007) A Duffy binding like domain (DBL-1) is involved in the NKp30 mediated recognition of Plasmodium falciparum parasitized erythrocytes by natural killer cells. J Infect Dis 195 (10): 1521–1531PubMedCrossRefGoogle Scholar
  28. Bouyou-Akotet MK, Issifou S, Meye JF, Kombila M, Ngou-Milama E, Luty AJ, et al (2004) Depressed natural killer cell cytotoxicity against Plasmodium falciparum-infected erythrocytes during first pregnancies. Clin Infect Dis 38 (3): 342–347PubMedCrossRefGoogle Scholar
  29. Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M (1996) Elevated proliferation and interleukin-4 release from CD4+ cells after chemotherapy in human Schistosoma haematobium infection. Eur J Immunol 26 (6): 1365–1370PubMedCrossRefGoogle Scholar
  30. van den Biggelaar AH, van Ree R, Rodrigues LC, Lell B, Deelder AM, Kremsner PG, et al (2000) Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 356 (9243): 1723–1727PubMedCrossRefGoogle Scholar
  31. Winkler S, Willheim M, Baier K, Aichelburg A, Kremsner PG, Graninger W (1999) Increased frequency of Th2-type cytokine-producing T cells in microfilaremic loiasis. Am J Trop Med Hyg 60 (4): 680–686PubMedGoogle Scholar
  32. Lell B, Borrmann S, Yazdanbakhsh M, Kremsner PG (2001) Atopy and malaria. Wien Klin Wochenschr 113 (23–24): 927–929PubMedGoogle Scholar
  33. Yazdanbakhsh M, Kremsner PG, van Ree R (2002) Allergy, parasites, and the hygiene hypothesis. Science 296 (5567): 490–494PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Michael Ramharter
    • 1
    • 2
  • Ayola A. Adegnika
    • 1
    • 3
  • Selidji T. Agnandji
    • 1
    • 3
  • Pierre Blaise Matsiegui
    • 1
    • 3
  • Martin P. Grobusch
    • 1
    • 4
  • Stefan Winkler
    • 2
  • Wolfgang Graninger
    • 2
  • Sanjeev Krishna
    • 5
  • Maria Yazdanbakhsh
    • 6
  • Benjamin Mordmüller
    • 1
    • 3
  • Bertrand Lell
    • 1
    • 3
  • Michel A. Missinou
    • 1
    • 3
  • Elie Mavoungou
    • 1
    • 3
  • Saadou Issifou
    • 1
    • 3
  • Peter G. Kremsner
    • 1
    • 3
    Email author
  1. 1.Medical Research UnitAlbert Schweitzer HospitalLambarénéGabon
  2. 2.Department of Medicine I, Division of Infectious DiseasesMedical University of ViennaAustria
  3. 3.Institute for Tropical Medicine, Department for ParasitologyUniversity of TübingenGermany
  4. 4.NHLS and CMIDUniversity of the WitwatersrandJohannesburgSouth Africa
  5. 5.Department of Cellular and Molecular MedicineSt. George's Hospital Medical SchoolLondonUK
  6. 6.Department of ParasitologyLeiden University Medical CenterLeidenNetherlands

Personalised recommendations